Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://theompnh100766.blogpixi.com/39282859/retaglutide-a-promising-glp-1-receptor-agonist